Population explosion, urbanization, changes in lifestyle management, improper food habits and various other
factors play focal contributors in the massive prevalence of type 2 diabetes mellitus in the developing countries. Although
insulin is the cornerstone in the management of type 1 diabetes; insulin, anti-hyperglycemic and hypoglycemic agents are
proved to be effective in type 2 diabetes, although their efficacy decreases with the progress of the disease. Moreover a
significant number of side effects, mostly hypoglycemia and weight gain have put a bar in using these drugs confidently.
Many novel therapeutic strategies with convincing efficacy and less adverse effects are currently emerging for providing
efficient means of treatment of this disorder. This article mainly focuses on newer and unconventional pharmaceutical or
biotechnical strategies that may or may not have been implied for the treatment of Type 2 Diabetes mellitus on a widescale
basis so far. These strategies are supposed to be efficient in controlling glycemic levels and possess a significant potential
to reduce the co-morbidities associated with this disease.
Keywords: Diabetes mellitus, dyslipidemia, glucose levels, hypoglycemic drugs, insulin, resistance.
Rights & PermissionsPrintExport